Optimal Timing of Coronary Artery Bypass Grafting in Haemodynamically Stable Patients after Myocardial Infarction.

Fiche publication

Date publication

mars 2023

Journal

Biomedicines

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BERNARD Alain

Tous les auteurs :
Bernard C, Morgant MC, Jazayeri A, Perrin T, Malapert G, Jazayeri S, Bernard A, Bouchot O

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36979958

Résumé

During the acute phase of myocardial infarction, the culprit artery must be revascularized quickly with angioplasty. Surgery then completes the procedure in a second stage. If emergency surgery is performed, the resulting death rate is high; 15-20% of patients are operated on within the first 48 h after the myocardial infarction. The timing of surgical revascularization and the patient's preoperative state influence the mortality rate. We aimed to evaluate the impact of surgery delay on morbimortality. Between 2007 and 2017, a retrospective monocentric study was conducted including 477 haemodynamically stable patients after myocardial infarction who underwent an urgent coronary bypass. Three groups were described, depending on the timing of the surgery: during the first 4 days (Group 1, = 111, 23%), 5 to 10 days (Group 2, = 242, 51%) and after 11 days (Group 3, = 124, 26%). The overall thirty-day mortality was 7.1% ( = 34). The death rate was significantly higher in Group 1 ( = 16; 14% vs. = 10; 4.0% vs. = 8; 6%, < 0.01). The mortality risk factors identified were age (OR: 1.08; CI 95%: 1.04-1.12; < 0.001), peripheral arteriopathy (OR: 3.31; CI 95%: 1.16-9.43; = 0.024), preoperative renal failure (OR: 6.39; CI 95%: 2.49-15.6; < 0.001) and preoperative ischemic recurrence (OR: 3.47; CI 95%: 1.59-7.48; < 0.01). Ninety-two patients presented with preoperative ischemic recurrence (19%), with no difference between the groups. The optimal timing for the surgical revascularization of MI seems to be after Day 4 in stable patients. However, timing is not the only factor influencing the death rate: the patient's health condition and disease severity must be considered in the individual management strategy.